EryDel
Healthcare
HQ: Urbino, Italy
Investors: 3
A late-stage biotechnology company specialized in drug delivery through red blood cells for the treatment of rare neurodegenerative diseases.
Investors (3)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Andera Partners | Exited | - | - | - |
| Origine SGR | Exited | - | - | - |
| Sofinnova Partners | Exited | - | - | Website |